An integrative molecular and genomic analysis of pediatric hemispheric low-grade gliomas: an update

Germline and somatic FGFR1 abnormalities in dysembryoplastic neuroepithelial tumors

(2016) Barbara Rivera et al.   ACTA NEUROPATHOLOGICA

The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary

(2016) David N. Louis et al.   ACTA NEUROPATHOLOGICA

Clinical and treatment factors determining long-term outcomes for adult survivors of childhood low-grade glioma: A population-based study

(2016) Rahul Krishnatry et al.   CANCER

MYB-QKI rearrangements in angiocentric glioma drive tumorigenicity through a tripartite mechanism

(2016) Pratiti Bandopadhayay et al.   NATURE GENETICS

Brigatinib, an anaplastic lymphoma kinase inhibitor, abrogates activity and growth in ALK-positive neuroblastoma cells, Drosophila and mice

(2016) Joachim T. Siaw et al.   Oncotarget

IDH mutation status and role of WHO grade and mitotic index in overall survival in grade II–III diffuse gliomas

(2015) Adriana Olar et al.   ACTA NEUROPATHOLOGICA

Características fenotípicas y genéticas en la neurofibromatosis tipo 1 en edad pediátrica

(2015) A. Duat Rodríguez et al.   ANALES DE PEDIATRIA

BRAFMutation andCDKN2ADeletion Define a Clinically Distinct Subgroup of Childhood Secondary High-Grade Glioma

(2015) Matthew Mistry et al.   JOURNAL OF CLINICAL ONCOLOGY

Low grade astrocytoma in children under the age of three years: a report from the Canadian pediatric brain tumour consortium

(2015) Donna L. Johnston et al.   JOURNAL OF NEURO-ONCOLOGY

The role of neuropathology in the management of patients with diffuse low grade glioma

(2015) Daniel P. Cahill et al.   JOURNAL OF NEURO-ONCOLOGY

Fusion genes withALKas recurrent partner in ependymoma-like gliomas: a new brain tumor entity?

(2015) Thale Kristin Olsen et al.   NEURO-ONCOLOGY

CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2008-2012

(2015) Quinn T. Ostrom et al.   NEURO-ONCOLOGY

Pediatric Low-Grade Ganglioglioma

(2015) Roy W.R. Dudley et al.   NEUROSURGERY

Successful Retreatment of a Child with a Refractory Brainstem Ganglioglioma with Vemurafenib

(2015) Dolly Aguilera et al.   PEDIATRIC BLOOD & CANCER

Oncogenic KIAA1549-BRAF fusion with activation of the MAPK/ERK pathway in pediatric oligodendrogliomas

(2015) Anupam Kumar et al.   Cancer Genetics

A neuropathology-based approach to epilepsy surgery in brain tumors and proposal for a new terminology use for long-term epilepsy-associated brain tumors

(2014) Ingmar Blumcke et al.   ACTA NEUROPATHOLOGICA

Targeted Therapy in Pediatric Low-Grade Glioma

(2014) John-Paul Kilday et al.   Current Neurology and Neuroscience Reports

Analysis of KIAA1549–BRAF fusion gene expression and IDH1/IDH2 mutations in low grade pediatric astrocytomas

(2014) Gabriela Rampazzo Cruz et al.   JOURNAL OF NEURO-ONCOLOGY

BRAF V600Emutations are frequent in dysembryoplastic neuroepithelial tumors and subependymal giant cell astrocytomas

(2014) Dakeun Lee et al.   JOURNAL OF SURGICAL ONCOLOGY

Response of recurrent BRAFV600E mutated ganglioglioma to Vemurafenib as single agent

(2014) Francesca del Bufalo et al.   Journal of Translational Medicine

Pilomyxoid astrocytoma treated successfully with vemurafenib

(2014) Mary Skrypek et al.   PEDIATRIC BLOOD & CANCER

Advances in the Management of Low-Grade Gliomas

(2014) Amulya A. Nageswara Rao et al.   Current Oncology Reports

BRAFV600E mutation is a negative prognosticator in pediatric ganglioglioma

(2013) Sonika Dahiya et al.   ACTA NEUROPATHOLOGICA

BRAF V600E Mutation Is Associated with mTOR Signaling Activation in Glioneuronal Tumors

(2013) Avanita S. Prabowo et al.   BRAIN PATHOLOGY

Brainstem Ganglioglioma Successfully Treated With Vemurafenib

(2013) Sarah Rush et al.   JOURNAL OF CLINICAL ONCOLOGY

BRAF alterations in pediatric low grade gliomas and mixed neuronal–glial tumors

(2013) Efthymios Dimitriadis et al.   JOURNAL OF NEURO-ONCOLOGY

Recurrent somatic alterations of FGFR1 and NTRK2 in pilocytic astrocytoma

(2013) David T W Jones et al.   NATURE GENETICS

Whole-genome sequencing identifies genetic alterations in pediatric low-grade gliomas

(2013)   NATURE GENETICS

Molecular genetics of low-grade gliomas: genomic alterations guiding diagnosis and therapeutic intervention. 11th Annual Frye-Halloran Brain Tumor Symposium

(2013) Pamela S. Jones et al.   Neurosurgical Focus

The molecular and cell biology of pediatric low-grade gliomas

(2013) Y-H Chen et al.   ONCOGENE

Genomic analysis of diffuse pediatric low-grade gliomas identifies recurrent oncogenic truncating rearrangements in the transcription factor MYBL1

(2013) L. A. Ramkissoon et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Interplay among BRAF, p16, p53, and MIB1 in pediatric low-grade gliomas

(2012) C. Horbinski et al.   NEURO-ONCOLOGY

Adult grade II diffuse astrocytomas are genetically distinct from and more aggressive than their paediatric counterparts

(2011) David T. W. Jones et al.   ACTA NEUROPATHOLOGICA

Analysis of BRAF V600E mutation in 1,320 nervous system tumors reveals high mutation frequencies in pleomorphic xanthoastrocytoma, ganglioglioma and extra-cerebellar pilocytic astrocytoma

(2011) Genevieve Schindler et al.   ACTA NEUROPATHOLOGICA

Genetic Aberrations Leading to MAPK Pathway Activation Mediate Oncogene-Induced Senescence in Sporadic Pilocytic Astrocytomas

(2011) K. Jacob et al.   CLINICAL CANCER RESEARCH

BRAFAlterations in Primary Glial and Glioneuronal Neoplasms of the Central Nervous System With Identification of 2 Novel KIAA1549

(2011) Alex Lin et al.   JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY

MYB upregulation and genetic aberrations in a subset of pediatric low-grade gliomas

(2010) Ruth G. Tatevossian et al.   ACTA NEUROPATHOLOGICA

Natural history and management of low-grade glioma in NF-1 children

(2010) Pablo Hernáiz Driever et al.   JOURNAL OF NEURO-ONCOLOGY

Cytogenetic analysis of paediatric astrocytoma using comparative genomic hybridisation and fluorescence in-situ hybridisation

(2010) Samantha J. Ward et al.   JOURNAL OF NEURO-ONCOLOGY

Association of molecular alterations, including BRAF, with biology and outcome in pilocytic astrocytomas

(2009) Craig Horbinski et al.   ACTA NEUROPATHOLOGICA

Duplication of 7q34 in Pediatric Low-Grade Astrocytomas Detected by High-Density Single-Nucleotide Polymorphism-Based Genotype Arrays Results in a NovelBRAFFusion Gene

(2009) Angela J. Sievert et al.   BRAIN PATHOLOGY

Pediatric Low-Grade Gliomas

(2009) Angela J. Sievert et al.   JOURNAL OF CHILD NEUROLOGY

Activation of the ERK/MAPK pathway: a signature genetic defect in posterior fossa pilocytic astrocytomas

(2009) Tim Forshew et al.   JOURNAL OF PATHOLOGY

Tandem Duplication Producing a Novel OncogenicBRAFFusion Gene Defines the Majority of Pilocytic Astrocytomas

(2008) David T.W. Jones et al.   CANCER RESEARCH

BRAF gene duplication constitutes a mechanism of MAPK pathway activation in low-grade astrocytomas

(2008) Stefan Pfister et al.   JOURNAL OF CLINICAL INVESTIGATION

Gliomas in Neurofibromatosis Type 1: A Clinicopathologic Study of 100 Patients

(2008) Fausto J. Rodriguez et al.   JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY

Outcome analysis of childhood low-grade astrocytomas

(2008) Paul G. Fisher et al.   PEDIATRIC BLOOD & CANCER

An Integrated Genomic Analysis of Human Glioblastoma Multiforme

(2008) D. W. Parsons et al.   SCIENCE